GLOBAL Webinar Series October 2022

Down Syndrome Regression Disorder: The Latest Research and Promising Treatments


In this insightful GLOBAL Webinar session, Drs. Espinosa and Santoro covered the recent research activities advancing the understanding of the condition known as Down Syndrome Regression Disorder (DSRD).

They discussed  the consensus criteria for diagnosis of this condition, an overview of symptoms, and current therapeutic option. Additionally Drs. Espinosa and Santoro shared news about an upcoming clinical trial designed to investigate the safety, efficacy, and mechanism of action of three distinct DSRD therapies.

The webinar attracted 475 registrations from 43 states and 18 countries (Australia, Bahamas, Belgium, Brazil, Canada, Chile, Costa Rica, France, Germany, India, Jamaica, Mexico, Netherlands, New Zealand, Peru, Spain, Sweden, and United Kingdom).


PowerPoint Presentation: Click to Download

Joaquín Espinosa, PhD is the Executive Director of the Linda Crnic Institute for Down Syndrome and Professor of Pharmacology at the University of Colorado School of Medicine. Dr. Espinosa directs a diverse research program with emphasis on Down syndrome that is supported by the NIH INCLUDE Project and the Global Down Syndrome Foundation. At the Crnic Institute, Dr. Espinosa directs the Human Trisome Project, a detailed natural history study of the population with Down syndrome. Dr. Espinosa currently serves as the Leader of the Administrative and Outreach Core of the NIH INCLUDE Project Data Coordinating Center. 

Jonathan Santoro, MD serves as the Director of Neuroimmunology and Demyelinating Disorders Program at Children’s Hospital Los Angeles. He is also an Assistant Professor of Neurology and Pediatrics at the Keck School of Medicine at the University of Southern California. Dr. Santoro is a passionate clinician-scientist and is one of only a handful of national clinician-scientists who treats neurologic disorders associated with Down syndrome. Dr. Santoro also has clinical research expertise in inflammation as it’s related to cerebrovascular disease and neurocognitive disorders such as Down Syndrome Regression Disorder. 


The presentation with audio as well as your questions and answers can be accessed using your GLOBAL Membership code. Not a Member? Join today! THANK YOU for supporting GLOBAL and our important work!

This webinar is one of the many benefits associated with Global Down Syndrome Foundation Membership. Learn more about GLOBAL’s award-winning magazine, Down Syndrome World™, and how to become a GLOBAL Member today.

If you have a family member or dear friend with Down syndrome, this webinar is for you! Not a Member? Join today! THANK YOU for supporting GLOBAL and our important work!

Important Notice

The Global Down Syndrome Foundation’s employees and/or volunteers are NOT acting as your medical professional or attorney. Responses you receive via electronic mail, phone, or in any other manner DO NOT create or constitute a doctor-patient or attorney-client relationship between you and the Global Down Syndrome Foundation (GLOBAL), or any employee of, or other person associated with, Global.

Information received from GLOBAL’s employees or volunteers, or from this website, should NOT be considered a substitute for the advice of a medical professional or lawyer. GLOBAL DOES NOT provide any medical or legal advice. You should consult with your own doctor or lawyer for medical or legal advice. This website is a general service that provides information over the internet. The information contained on this website is general information and should not be construed as medical advice to be applied to any specific factual situations.

GLOBAL Webinars Archive